Viral carcinogenesis: Revelation of molecular mechanisms and etiology of human disease

Carcinogenesis

Volumn 21, Issue 3, 2000, Pages 405-426

  Butel, Janet S ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; ONCOPROTEIN; VIRUS DNA;

DNA VIRUS; ENVIRONMENTAL FACTOR; EPSTEIN BARR VIRUS; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; HUMAN T CELL LEUKEMIA VIRUS; NONHUMAN; PAPILLOMA VIRUS; PRIORITY JOURNAL; RETROVIRUS; REVIEW; RNA VIRUS; VIRUS CARCINOGENESIS; VIRUS INFECTION; VIRUS ONCOGENE;

EID: 0034060617     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/21.3.405     Document Type: Review

References (169)

1. Coffin, J.M., Hughes, S.H. and Varmus, H.E. (eds) (1997) Retroviruses. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York, NY.
2. Fields, B.N., Knipe, D.M., Howley, P.M., Chanock, R.M., Melnick, J.L., Monath, T.P., Roizman, B. and Straus, S.E. (eds) (1996) Fields Virology. 3rd edn. Lippincott-Raven, Philadelphia.
3. Parsonnet, J. (ed.) (1999) Microbes and Malignancy: Infection as a Cause of Human Cancers. Oxford University Press, Oxford, UK.
4. Newton, R., Beral, V. and Weiss, R.A. (eds) (1999) Infections and Human Cancer. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
5. Peters, G. and Vousden, K.H. (eds) (1999) Oncogenes and Tumour Suppressors, Oxford University Press, Oxford, UK.
6. Balmain, A., Brown, R. and Harris, C.C. (2000) Carcinogenesis, 21, 339-530.
7. Rous, P. (1911) Transmission of a malignant new growth by means of a cell-free filtrate. J. Am. Med. Assoc., 56, 198.
8. Vogt, P.K. (1997) Historical introduction to the general properties of retroviruses. In Coffin, J.M, Hughes, S.H. and Varmus, H.E. (eds) Retroviruses. Cold Spring Harbor Laboratory Press, Cold Spring Harbor. New York, NY, pp. 1-25.
9. Temin, H.M. and Rubin, H. (1958) Characteristics of an assay for Rous sarcoma virus and Rous sarcoma cells in tissue culture. Virology, 6, 669-688.
10. Baltimore, D. (1970) RNA-dependent DNA polymerase in virions of RNA tumour viruses. Nature, 226, 1209-1211.
11. Temin, H.M. and Mizutani, S. (1970) RNA-dependent DNA polymerase in virions of Rous sarcoma virus. Nature, 226, 1211-1213.
12. Stéhelin, D., Varmus, H.E., Bishop, J.M. and Vogt, P.K. (1976) DNA related to the transforming gene(s) of avian sarcoma viruses is present in normal avian DNA. Nature, 260, 170-173.
13. Hunter, T. (1991) Cooperation between oncogenes. Cell, 64, 249-270.
14. Vogt, P.K., Bos, T.J. and Doolittle, R.F. (1987) Homology between the DNA-binding domain of the GCN4 regulatory protein of yeast and the carboxyl-terminal region of a protein coded for by the oncogene jun. Proc. Natl Acad. Sci. USA, 84, 3316-3319.
15. Rosenberg, N. and Jolicoeur, P. (1997) Retroviral pathogenesis. In Coffin, J.M., Hughes, S.H. and Varmus, H.E. (eds) Retroviruses. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, pp. 475-585.
16. Telesnitsky, A. and Goff, S.P. (1997) Reverse transcriptase and the generation of retroviral DNA. In Coffin, J.M., Hughes, S.H. and Varmus, H.E. (eds) Retroviruses. Cold Spring Harbor Laboratory Press, Cold Spring Harbor Laboratory, NY, pp. 121-160.
17. Kung, H.J., Boerkoel, C. and Carter, T.H. (1991) Retroviral mutagenesis of cellular oncogenes: a review with insights into the mechanisms of insertional activation. Curr. Top. Microbiol. Immunol., 171, 1-25
18. Fourel, G., Trepo, C., Bougueleret, L., Henglein, B., Ponzetto, A., Tiollais, P. and Buendia, M.A. (1990) Frequent activation of N-myc genes by hepadnavirus insertion in woodchuck liver tumours. Nature, 347, 294-298.
19. Luther, S.A. and Acha-Orbea, H. (1997) Mouse mammary tumor virus: immunological interplays between virus and host. Adv. Immunol., 65, 139-243.
20. Cole, C.N. (1996) Polyomavirinae: the viruses and their replication. In Fields, B.N., Knipe, D.M., Howley, P.M., Chanock, R.M., Melnick, J.L., Monath, T.P., Roizman, B. and Straus, S.E. (eds) Fields Virology. 3rd edn. Lippincott-Raven, Philadelphia, PA, Vol. 2, pp. 1997-2025.
21. Howley, P.M. (1996) Papillomavirinae: the viruses and their replication. In Fields, B.N., Knipe, D.M., Howley, P.M., Chanock, R.M., Melnick, J.L., Monath, T.P., Roizman, B. and Straus, S.E. (eds) Fields Virology. 3rd edn. Lippincott-Raven, Philadelphia, PA, Vol. 2, pp. 2045-2076.
22. Shenk, T. (1996) Adenoviridae: the viruses and their replication. In Fields, B.N., Knipe, D.M., Howley, P.M., Chanock, R.M., Melnick, J.L., Monath, T.P., Roizman, B. and Straus, S.E. (eds) Fields Virology. 3rd edn. Lippincott-Raven, Philadelphia, PA, Vol. 2, pp. 2111-2148.
23. Pipas, J.M. (1992) Common and unique features of T antigens encoded by the polyomavirus group. J. Virol., 66, 3979-3985.
24. Butel, J.S. and Lednicky, J.A. (1999) Cell and molecular biology of simian virus 40: implications for human infections and disease. J. Natl Cancer Inst., 91, 119-134.
25. Neil, J.C., Cameron, E.R. and Baxter, E.W. (1997) p53 and tumour viruses: catching the guardian off-guard. Trends Microbiol., 5, 115-120.
26. Conzen, S.D. and Cole, C.N. (1994) The transforming proteins of simian virus 40. Semin. Virol., 5, 349-356.
27. Nevins, J.R. and Vogt, P.K. (1996) Cell transformation by viruses. In Fields, B.N., Knipe, D.M., Howley, P.M., Chanock, R.M., Melnick, J.L., Monath, T.P., Roizman, B. and Straus, S.E. (eds) Fields Virology. 3rd edn. Lippincott-Raven, Philadelphia, PA, Vol. 1. pp. 301-343.
28. Imreh, S., Szekely, L., Wiman, K.G. and Klein, G. (1997) Mechanisms of oncogene perturbation. In Peters, G. and Vousden, K.H. (eds) Oncogenes and Tumour Suppressors. Oxford University Press, Oxford, UK, pp. 3-32.
29. Lane, D.P. and Crawford, L.V. (1979) T antigen is bound to a host protein in SV40-transformed cells. Nature, 278, 261-263.
30. Linzer, D.I.H. and Levine, A.J. (1979) Characterization of a 54K dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells. Cell, 17, 43-52.
31. Finlay, C.A., Hinds, P.W. and Levine, A.J. (1989) The p53 proto-oncogene can act as a suppressor of transformation. Cell, 57, 1083-1093.
32. Whyte, P., Buchkovich, K.J., Horowitz, J.M., Friend, S.H., Raybuck, M., Weinberg, R.A. and Harlow, E. (1988) Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product. Nature, 334, 124-129.
33. Lane, D.P. (1992) Cancer, p53, guardian of the genome. Nature, 358, 15-16.
34. Freedman, D.A. and Levine, A.J. (1999) Regulation of the p53 protein by the MDM2 oncoprotein - Thirty-eighth G.H.A. Clowes Memorial Award Lecture. Cancer Res., 59, 1-7.
35. Amundson, S.A., Myers, T.G. and Fornace, A.J., Jr (1998) Roles for p53 in growth arrest and apoptosis: putting on the brakes after genotoxic stress. Oncogene, 17, 3287-3299.
36. Sherr, C.J. (1998) Tumor surveillance via the ARF-p53 pathway. Genes Dev., 12, 2984-2991.
37. Lee, S.S., Weiss, R.S. and Javier, R.T. (1997) Binding of human virus oncoproteins to hDlg/SAP97, a mammalian homolog of the Drosophila discs large tumor suppressor protein. Proc. Natl Acad. Sci. USA, 94, 6670-6675.
38. Parada, L.F., Tabin, C.J., Shih, C. and Weinberg, R.A. (1982) Human EJ bladder carcinoma oncogene is homologue of Harvey sarcoma virus ras gene. Nature, 297, 474-478.
39. Der, C.J., Krontiris, T.G. and Cooper, G.M. (1982) Transforming genes of human bladder and lung carcinoma cell lines are homologous to the ras genes of Harvey and Kirsten sarcoma viruses. Proc. Natl Acad. Sci. USA, 79, 3637-3640.
40. Sukumar, S., Notario, V., Martin-Zanca, D. and Barbacid, M. (1983) Induction of mammary carcinomas in rats by nitroso-methylurea involves malignant activation of H-ras-l locus by single point mutations. Nature, 306, 658-661.
41. Look, A.T. (1997) Oncogenic transcription factors in the human acute leukemias. Science, 278, 1059-1064.
42. Greenblatt, M.S., Bennett, W.P., Hollstein, M. and Harris, C.C. (1994) Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res., 54, 4855-4878.
43. Harris, C.C. (1996) Structure and function of the p53 tumor suppressor gene: clues for rational cancer therapeutic strategies. J. Natl Cancer Inst., 88, 1442-1455.
44. Bishop, J.M. (1991) Molecular themes in oncogenesis. Cell, 64, 235-248.
45. Weinberg, R.A. (1989) Oncogenes, antioncogenes and the molecular bases of multistep carcinogenesis. Cancer Res., 49, 3713-3721.
46. Howley, P.M. and Münger, K. (1999) Human papillomaviruses and squamous cell carcinomas. In Parsonnet, J. (ed.) Microbes and Malignancy: Infection as a Cause of Human Cancers. Oxford University Press, Oxford, UK, pp. 157-179.
47. Rassoulzadegan, M., Cowie, A., Carr, A., Glaichenhaus, N., Kamen, R. and Cuzin, F. (1982) The roles of individual polyoma virus early proteins in oncogenic transformation. Nature, 300, 713-718.
48. Land, H., Parada, L.F. and Weinberg, R.A. (1983) Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes. Nature, 304, 596-602.
49. Ruley, H.E. (1983) Adenovirus early region 1A enables viral and cellular transforming genes to transform primary cells in culture. Nature, 304, 602-606.
50. Hanahan, D. (1989) Transgenic mice as probes into complex systems. Science, 246, 1265-1275.
51. Sepulveda, A.R., Finegold, M.J., Smith, B., Slagle, B.L., DeMayo, J.L., Shen, R.F., Woo, S.L. and Butel, J.S. (1989) Development of a transgenic mouse system for the analysis of stages in liver carcinogenesis using tissue-specific expression of SV40 large T-antigen controlled by regulatory elements of the human α-1-antitrypsin gene. Cancer Res., 49, 6108-6117.
52. Merlino, G. (1994) Transgenic mice as models for tumorigenesis. Cancer Investigation, 12, 203-213.
53. Adams, J.M. and Cory, S. (1991) Transgenic models of tumor development. Science, 254, 1161-1167.
54. Attardi, L.D. and Jacks, T. (1999) The role of p53 in tumour suppression: lessons from mouse models. Cell Mol. Life Sci., 55, 48-63.
55. Ghebranious, N. and Donehower, L.A. (1998) Mouse models in tumor suppression. Oncogene, 17, 3385-3400.
56. Pereira-Smith, O.M. and Smith, J.R. (1988) Genetic analysis of indefinite division in human cells: identification of four complementation groups. Proc. Natl Acad. Sci. USA, 85, 6042-6046.
57. Chen, T.M., Pecoraro, G. and Defendi, V. (1993) Genetic analysis of in vitro progression of human papillomavirus-transfected human cervical cells. Cancer Res., 53, 1167-1171.
58. Jha, K.K., Banga, S., Palejwala, V. and Ozer, H.L. (1998) SV40-mediated immortalization. Exp. Cell Res., 245, 1-7.
59. Bérubé, N.G., Smith, J.R. and Pereira-Smith, O.M. (1998) Insights from model systems: the genetics of cellular senescence. Am. J. Hum. Genet., 62, 1015-1019.
60. zur Hausen, H. (1999) Viral oncogenesis. In Parsonnet, J. (ed.) Microbes and Malignancy: Infection as a Cause of Human Cancers. Oxford University Press, Oxford, UK, pp. 107-130.
61. Teodoro, J.G. and Branton, P.E. (1997) Regulation of apoptosis by viral gene products. J. Virol., 71, 1739-1746.
62. White, E. (1996) Life, death and the pursuit of apoptosis. Genes Dev., 10, 1-15.
63. White, E. (1995) Regulation of p53-dependent apoptosis by E1A and E1B. Curr. Top. Microbiol. Immunol., 199, 33-58.
64. Gottlieb, T.M. and Oren, M. (1998) p53 and apoptosis. Semin. Cancer Biol., 8, 359-368.
65. Ciuffo, G. (1907) Innesto positivo con tiltrado di verrucae volgare. G. Ital. Mal. Venereol., 48, 12-15.
66. Ellermann, V. and Bang, O. (1908) Experimentelle Leukämie bei Hühnern. Centralbl. f. Bakt. Abt. I (Orig.). 46, 595-609.
67. Gross, L. (1950) Susceptibility of newborn mice of an otherwise apparently 'resistant' strain to inoculation with leukemia. Proc. Soc. Exp. Biol. Med., 73, 246-248.
68. Epstein, M.A., Achong, B.G. and Barr, Y.M. (1964) Virus particles in cultured lymphoblasts from Burkitt's lymphoma. Lancet, i, 702-703.
69. Dane, D.S., Cameron, C.H. and Briggs, M. (1970) Virus-like particles in serum of patients with Australia-antigen-associated hepatitis. Lancet, i, 695-698.
70. Poiesz, B.J., Ruscetti, F.W., Gazdar, A.F., Bunn, P.A., Minna, J.D. and Gallo, R.C. (1980) Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc. Natl Acad. Sci. USA, 77, 7415-7419.
71. Yoshida, M., Miyoshi, I. and Hinuma, Y. (1982) Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc. Natl Acad Sci. USA, 79, 2031-2035.
72. Barré-Sinoussi, F., Chermann, J.C., Rey, F., Nugeyre, M.T., Chamaret, S., Gruest, J., Dauguet, C., Axler-Blin, C., Vézinet-Brun, F., Rouzioux, C., Rozenbaum, W. and Montagnier, L. (1983) Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science, 220, 868-871.
73. Gallo, R.C, Salahuddin, S.Z., Popovic, M. et al. (1984) Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS. Science, 224, 500-503.
74. Levy, J.A., Hoffman, A.D., Kramer, S.M., Landis, J.A., Shimabukuro, J.M. and Oshiro, L.S. (1984) Isolation of lymphocytopathic retroviruses from San Francisco patients with AIDS. Science, 225, 840-842.
75. Choo, Q.L., Kuo, G., Weiner, A.J., Overby, L.R., Bradley, D.W. and Houghton, M. (1989) Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science, 244, 359-362.
76. Chang, Y., Cesarman, E., Pessin, M.S., Lee, F., Culpepper, J., Knowles, D.M. and Moore, P.S. (1994) Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma Science, 266, 1865-1869.
77. Parkin, D.M., Pisani, P., Muñoz, N. and Ferlay, J. (1999) The global health burden of infection associated cancers. Cancer Surv., 33, 5-33.
78. Buendia, M.A. (1992) Hepatitis B viruses and hepatocellular carcinoma. Adv. Cancer Res., 59, 167-226.
79. Chisari, F.V. and Ferrari, C. (1995) Hepatitis B virus immunopathogenesis. Ann. Rev. Immunol., 13, 29-60.
80. Hollinger, F.B. (1996) Hepatitis B virus. In Fields, B.N., Knipe, D.M., Howley, P.M., Chanock, R.M. Melnick, J.L., Monath, T.P., Roizman, B. and Straus, S.E. (eds) Fields Virology. 3rd edn. Lippincott-Raven, Philadelphia, PA, Vol. 2, pp. 2739-2807.
81. Chung, R.T. and Liang, T.J. (1999) Hepatitis C virus and hepatocellular carcinoma. In Parsonnet, J. (ed.) Microbes and Malignancy: Infection as a Cause of Human Cancers. Oxford University Press, Oxford, UK, pp. 267-288.
82. Robinson, W.S. (1999) Hepatitis B virus and hepatocellular carcinoma. In Parsonnet, J. (ed.) Microbes and Malignancy: Infection as a Cause of Human Cancers. Oxford University Press, Oxford, UK, pp. 232-266.
83. Tanaka, H. and Tsukuma, H. (1999) Hepatitis C virus. Cancer Surv., 33, 213-235.
84. Jeannel, D., Bouvier, G. and Hubert, A. (1999) Nasopharyngeal carcinoma: an epidemiological approach to carcinogenesis. Cancer Surv., 33, 125-155.
85. Raah-Traub, N. (1999) Epstein-Barr virus, lymphoproliferative diseases and nasopharyngeal carcinoma. In Parsonnet, J. (ed.) Microbes and Malignancy: Infection as a Cause of Human Cancers. Oxford University Press, Oxford, UK, pp. 180-206.
86. Brooks, L.A., Crook, T. and Crawford, D.H. (1999) Epstein-Barr virus and lymphomas. Cancer Surv., 33, 99-123.
87. zur Hausen, H. (1996) Papillomavirus infections - a major cause of human cancers. Biochim. Biophys Acta, 1288, F55-F78.
88. Herrero, R. and Muñoz, N. (1999) Human papillomavirus and cancer. Cancer Surv., 33, 75-98.
89. Tajima, K. and Takezaki, T. (1999) Human T cell leukaemia virus type I. Cancer Surv., 33, 191-211.
90. Yoshida, M. (1999) Human C-type oncoviruses and T-cell leukemia/ lymphoma. In Parsonnet, J. (ed.) Microbes and Malignancy: Injection as a Cause of Human Cancers. Oxford University Press, Oxford, UK, pp. 289-309.
91. Chang, Y. (1999) KSHV, Kaposi's sarcoma and related lymphoproliferative disorders. In Parsonnet, J. (ed.) Microbes and Malignancy: Infection as a Cause of Human Cancers. Oxford University Press, Oxford, UK, pp. 207-231.
92. Boshoff, C. (1999) Kaposi's sarcoma associated herpesvirus. Cancer Surv., 33, 157-190.
93. Carbone, M., Rizzo, P. and Pass, H.I. (1997) Simian virus 40, poliovaccines and human tumors: a review of recent developments. Oncogene, 15, 1877-1888.
94. zur Hausen, H. (1991) Viruses in human cancers. Science, 254, 1167-1173.
95. Relman, D.A. (1999) Chronic host-parasite interactions. In Parsonnet, J. (ed.) Microbes and Malignancy: Infection as a Cause of Human Cancers. Oxford University Press, Oxford, UK, pp. 19-34.
96. Smith, G.L. (1994) Virus strategies for evasion of the host response to infection. Trends Microbiol., 2, 81-88.
97. Schulz, T.F. (1998) Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8). J. Gen. Virol., 79, 1573-1591.
98. Senkevich, T.G., Koonin, E.V., Bugert, J.J., Darai, G. and Moss, B. (1997) The genome of molluscum contagiosum virus: analysis and comparison with other poxviruses. Virology, 233, 19-12.
99. McFadden, G. (1998) Even viruses can learn to cope with stress. Science, 279, 40-11.
100. Ahmed, R., Morrison, L.A. and Knipe, D.M. (1996) Persistence of viruses. In Fields, B.N., Knipe, D.M., Howley, P.M., Chanock, R.M., Melnick, J.L., Monath, T.P., Roizman, B. and Straus, S.E. (eds) Fields Virology. 3rd edn. Lippincott-Raven, Philadelphia, PA, Vol. 1, pp. 219-249.
101. Whitton, J.L. and Oldstone, M.B.A. (1996) Immune response to viruses. In Fields, B.N., Knipe, D.M., Howley, P.M., Chanock, R.M., Melnick, J.L., Monath, T.P., Roizman, B. and Straus, S.E. (eds) Fields Virology. 3rd edn. Lippincott-Raven, Philadelphia, PA, Vol. 1, pp. 345-374.
102. Wiertz, E.J.H.J., Jones, T.R., Sun, L., Bogyo, M., Geuze, H.J. and Ploegh, H.L. (1996) The human cytomegalovirus US11 gene product dislocates MHC class I heavy chains from the endoplasmic reticulum to the cytosol. Cell, 84, 769-779.
103. Levitskaya, J., Coram, M., Levitsky, V., Imreh, S., Steigerwald-Mullen, P.M., Klein, G., Kurilla, M.G. and Masucci, M.G. (1995) Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1. Nature, 375, 685-688.
104. Ganem, D. (1996) Hepadnaviridae and their replication. In Fields, B.N., Knipe, D.M., Howley, P.M., Chanock, R.M., Melnick, J.L., Monath, T.P., Roizman, B. and Straus, S.E. (eds) Fields Virology. 3rd edn. Lippincott-Raven. Philadelphia, PA, Vol. 2, pp. 2703-2737.
105. Wild, C.P. and Hall, A.J. (1999) Hepatitis B virus and liver cancer: unanswered questions. Cancer Surv., 33, 35-54.
106. Beasley, R.P., Hwang, L.Y., Lin, C.C. and Chien, C.S. (1981) Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22,707 men in Taiwan. Lancet, 2, 1129-1133.
107. World Health Organization Consultation Group (1999) Global surveillance and control of hepatitis C: report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium. J. Viral Hepatitis, 6, 35-47.
108. Rickinson, A.B. and Kieff, E. (1996) Epstein-Barr virus. In Fields, B.N., Knipe, D.M., Howley, P.M., Chanock, R.M., Melnick, J.L., Monath, T.P., Roizman, B. and Straus, S.E. (eds) Fields Virology. 3rd edn. Lippincott-Raven, Philadelphia, PA, Vol. 2, pp. 2397-2446.
109. Cohen, S.M. (1999) Infection, cell proliferation and malignancy. In Parsonnet, J. (ed.) Microbes and Malignancy: Infection as a Cause of Human Cancers, Oxford University Press, Oxford, UK, pp. 89-106.
110. Shah, K.V. and Howley, P.M. (1996) Papillomaviruses. In Fields, B.N., Knipe, D.M., Howley, P.M., Chanock, R.M., Melnick, J.L., Monath, T.P., Roizman, B. and Straus, S.E. (eds) Fields Virology. 3rd edn. Lippincott-Raven. Philadelphia, PA, Vol. 2, pp. 2077-2109.
111. Bosch, F.X., Manos, M.M., Muñz, N., Sherman, M., Jansen, A.M., Peto, J., Schiffman, M.H., Moreno, V., Kurman, R., Shah, K.V. and International Biological Study on Cervical Cancer (ISBCC) Study Group (1995) Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J. Natl Cancer Inst., 87, 796-802.
112. Clarke, B. (1997) Molecular virology of hepatitis C virus. J. Gen. Virol., 78, 397-2410.
113. Freund, R., Mandel, G., Carmichael, G.G., Barncastle, J.P., Dawe, C.J. and Benjamin, T.L. (1987) Polyomavirus tumor induction in mice: influences of viral coding and noncoding sequences on tumor profiles. J. Virol., 61, 2232-2239.
114. Montesano, R., Hainaut, P. and Wild, C.P. (1997) Hepatocellular carcinoma: from gene to public health. J. Natl Cancer Inst., 89, 1844-1851.
115. Perera, F.P. (1996) Molecular epidemiology: insights into cancer susceptibility, risk assessment and prevention. J. Natl Cancer Inst., 88, 496-509.
116. Storey, A., Thomas, M., Kalita, A., Harwood, C., Gardiol, D., Mantovani, F., Breuer, J., Leigh, I.M., Matlashewski, G. and Banks, L. (1998) Role of a p53 polymorphism in the development of human papillomavirus-associated cancer. Nature, 393, 229-234.
117. DiMaio, D., Lai, C.C. and Klein, O. (1998) Virocrine transformation: the intersection between viral transforming proteins and cellular signal transduction pathways. Annu. Rev. Microbiol., 52, 397-421.
118. Mosialos, G., Birkenbach, M., Yalamanchili, R., VanArsdale, T., Ware, C. and Kieff, E. (1995) The Epstein-Barr virus transforming protein LMPI engages signaling proteins for the tumor necrosis factor receptor family. Cell, 80, 389-399.
119. Wilson, J.B., Bell, J.L. and Levine, A.J. (1996) Expression of Epstein-Barr virus nuclear antigen-1 induces B cell neoplasia in transgenic mice. EMBO J., 15, 3117-3126.
120. Benn, J. and Schneider, R.J. (1994) Hepatitis B virus HBx protein activates Ras-GTP complex formation and establishes a Ras, Raf. MAP kinase signaling cascade. Proc. Natl Acad. Sci. USA, 91, 10350-10354.
121. Butel, J.S., Lee, T.H. and Slagle, B.L. (1996) Is the DNA repair system involved in hepatitis-B-virus-mediated hepatocellular carcinogenesis? Trends Microbiol., 4, 119-124.
122. Becker, S.A., Lee, T.H., Butel, J.S. and Slagle, B.L. (1998) Hepatitis B virus X protein interferes with cellular DNA repair. J. Virol., 72, 266-272.
123. Jia, L., Wang, X.W. and Harris, C.C. (1999) Hepatitis B virus X protein inhibits nucleotide excision repair. Int. J. Cancer, 80, 875-879.
124. Sakamuro, D., Furukawa, T. and Takegami, T. (1995) Hepatitis C virus nonstructural protein NS3 transforms NIH 3T3 cells. J. Virol., 69, 3893-3896.
125. Ishido, S. and Hotta, H. (1998) Complex formation of the nonstructural protein 3 of hepatitis C virus with the p53 tumor suppressor. FEBS Lett., 438, 258-262.
126. Tzahar, E., Moyer, J.D., Waterman, H., Barbacci, E.G., Bao, J., Levkowitz, G., Shelly, M., Strano, S., Pinkas-Kramarski, R., Pierce, J.H., Andrews, G.C. and Yarden, Y. (1998) Pathogenic poxviruses reveal viral strategies to exploit the ErbB signaling network. EMBO J., 17, 5948-5963.
127. Yin, M.J., Christerson, L.B., Yamamoto, Y., Kwak, Y.T., Xu, S., Mercurio, F., Barbosa, M., Cobb, M.H. and Gaynor, R.B. (1998) HTLV-I Tax protein binds to MEKK1 to stimulate IκB kinase activity and NF-κB activation. Cell, 93, 875-884.
128. Kao, S.Y. and Marriott, S.J. (1999) Disruption of nucleotide excision repair by the human T-cell leukemia virus type 1 Tax protein. J. Virol., 73, 4299-4304.
129. Philpott, S.M. and Buehring, G.C. (1999) Defective DNA repair in cells with human T-cell leukemia/bovine leukemia viruses: role of tax gene. J. Natl Cancer Inst., 91, 933-942.
130. Newton, R., Beral, V. and Weiss, R. (1999) Human immunodeficiency virus infection and cancer. Cancer Surv., 33, 237-262.
131. Barillari, G., Gendelman, R., Gallo, R.C. and Ensoli, B. (1993) The Tat protein of human immunodeficiency virus type 1, a growth factor for AIDS Kaposi sarcoma and cytokine-activated vascular cells, induces adhesion of the same cell types by using integrin receptors recognizing the RGD amino acid sequence. Proc. Natl Acad. Sci. USA, 90, 7941-7945.
132. Evans, A.S. and Mueller, N.E. (1990) Viruses and cancer: causal associations. Ann. Epidemiol., 1, 71-92.
133. Hill, A.B. (1965) Environment and disease: association or causation? Proc. R. Soc. Med., 58, 295-300.
134. Hill, A.B. and Hill, I.D. (ed.) (1991) Bradford Hill's Principles of Medical Statistics. 12th edn. Edward Arnold, London, UK.
135. de-Thé,G. (1982) Epidemiology of Epstein-Barr virus and associated diseases in man. In Roizman, B. (ed.) The Herpesviruses. Plenum Press, New York, NY, pp. 25-103.
136. zur Hausen, H. (1976) Condylomata acuminata and human genital cancer. Cancer Res., 36, 794.
137. Dürst, M., Gissmann, L., Ikenberg, H. and zur Hausen, H. (1983) A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proc. Natl Acad. Sci. USA, 80, 3812-3815.
138. Renne, R., Zhong, W., Herndier, B., McGrath, M., Abbey, N., Kedes, D. and Ganem, D. (1996) Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture. Nature Med., 2, 342-346.
139. Lednicky, J.A. and Butel, J.S. (1999) Polyomaviruses and human tumors: a brief review of current concepts and interpretations. Front. Biosci., 4, D153-D164.
140. Bergsagel, D.J., Finegold, M.J., Butel, J.S., Kupsky, W.J. and Garcea, R.L. (1992) DNA sequences similar to those of simian virus 40 in ependymomas and choroid plexus tumors of childhood. N. Engl. J. Med., 326, 988-993.
141. Carbone, M., Pass, H.I., Rizzo, P., Marinetti, M., Di Muzio, M., Mew, D.J., Levine, A.S. and Procopio, A. (1994) Simian virus 40-like DNA sequences in human pleural mesothelioma. Oncogene, 9, 1781-1790.
142. Bernards, R. and van der Eb, A.J. (1984) Adenovirus: transformation and oneogenicity. Biochim. Biophys. Acta, 783, 187-204.
143. Tevethia, S.S. (1990) Recognition of simian virus 40 T antigen by cytotoxic T lymphocytes. Mol. Biol. Med., 7, 83-96.
144. Bright, R.K., Shearer, M.H. and Kennedy, R.C. (1994) Immunization of BALB/c mice with recombinant simian virus 40 large tumor antigen induces antibody-dependent cell-mediated cytotoxicity against simian virus 40-transformed cells: an antibody-based mechanism for tumor immunity. J. Immunol., 153, 2064-2071.
145. Xie, Y.C., Hwang, C., Overwijk, W., Zeng, Z., Eng, M.H., Mulé, J.J., Imperiale, M.J., Restifo, N.P. and Sanda, M.G. (1999) Induction of tumor antigen-specific immunity in vivo by a novel vaccinia vector encoding safety-modified simian virus 40 T antigen. J. Natl Cancer Inst., 91, 169-175.
146. Van Dyke, T.A. (1994) Analysis of viral-host protein interactions and tumorigenesis in transgenic mice. Semin. Cancer Biol., 5, 47-60.
147. Greenhalgh, D.A. and Roop, D.R. (1994) Dissecting molecular carcinogenesis: development of transgenic mouse models by epidermal gene targeting. Adv. Cancer Res., 64, 247-296.
148. Brinster, R.L., Chen, H.Y, Messing, A., Van Dyke, T., Levine, A.J. and Palmiter, R.D. (1984) Transgenic mice harboring SV40 T-antigen genes develop characteristic brain tumors. Cell, 37, 367-379.
149. Ewald, D., Li, M., Efrat, S., Auer, G., Wall, R.J., Furth, P.A. and Hennighausen, L. (1996) Time-sensitive reversal of hyperplasia in transgenic mice expressing SV40 T antigen. Science, 273, 1384-1386.
150. Griep, A.E. and Lambert, P.F. (1994) Role of papillomavirus oncogenes in human cervical cancer: transgenic animal studies. Proc. Soc. Exp. Biol. Med., 206, 24-34.
151. Chisari, F.V. (1996) Hepatitis B virus transgenic mice: models of viral immunobiology and pathogenesis. Curr. Topics Microbiol. Immunol., 206, 149-173.
152. Donehower, L.A., Harvey, M., Slagle, B.L., McArthur, M.J., Montgomery, C.A.J., Butel, J.S. and Bradley, A. (1992) Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature, 356, 215-221.
153. Jacks, T., Remington, L., Williams, B.O., Schmitt, E.M., Halachmi, S., Bronson, R.T. and Weinberg, R.A. (1994) Tumor spectrum analysis in p53-mutant mice. Curr. Biol., 4, 1-7.
154. Donehower, L.A., Godley, L.A., Aldaz, C.M., Pyle, R., Shi, Y.P., Pinkel, D., Gray, J., Bradley, A., Medina, D. and Varmus, H.E. (1995) Deficiency of p53 accelerates mammary tumorigenesis in Wnt-I transgenic mice and promotes chromosomal instability. Genes Dev., 9, 882-895.
155. Akoum, A., Lavoie J., Drouin, R., Jolicoeur, C., Lemay, A., Maheux, R. and Khandjian, E.W. (1999) Physiological and cytogenetic characterization of immortalized human endometriotic cells containing episomal simian virus 40 DNA. Am. J. Pathol., 154, 1245-1257.
156. Salewski, H., Bayer, T.A., Eidhoff, U., Preuss, U., Weggen, S. and Scheidtmann, K.H. (1999) Increased oncogenicity of subclones of SV40 large T-induced neuroectodermal tumor cell lines after loss of large T expression and concomitant mutation in p53. Cancer Res., 59, 1980-1986.
157. Smith, M. (1997) Considerations on a possible viral etiology for B-precursor acute lymphoblastic leukemia of childhood. J. Immunother., 20, 89-100.
158. Malkin, D., Li, F.P., Strong, L.C., Fraumeni, J.F., Jr, Nelson, C.E., Kim, D.H., Kassel, J., Gryka, M.A., Bischoff, F.Z., Tainsky, M.A. and Friend, S.H. (1990) Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas and other neoplasms. Science, 250, 1233-1238.
159. Heslop, H.E., Ng, C.Y., Li, C., Smith, C.A., Loftin, S.K., Krance, R.A., Brenner, M.K. and Rooney, C.M. (1996) Long term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes. Nature Med., 2, 551-555.
160. Testa, J.R., Carbone, M., Hirvonen, A., Khalili, K., Krynska, B., Linnainmaa, K., Pooley, F.D., Rizzo, P., Rusch, V. and Xiao, G.H. (1998) A multi-institutional study confirms the presence and expression of simian virus 40 in human malignant mesotheliomas. Cancer Res., 58, 4505-4509.
161. Mayall, F.G., Jacobson, G. and Wilkins, R. (1999) Mutations of p53 gene and SV40 sequences in asbestos associated and non-asbestos-associated mesotheliomas. J. Clin. Pathol., 52, 291-293.
162. Chang, M.H., Chen, C.J., Lai, M.S., Hsu, H.M., Wu, T.C., Kong, M.S., Liang, D.C., Shau, W.Y. and Chen, D.S. for the Taiwan Childhood Hepatoma Study Group. (1997) Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. N. Engl. J. Med, 336, 1855-1859.
163. Murakami, M., Gurski, K.J. and Steller, M.A. (1999) Human papillomavirus vaccines for cervical cancer. J. Immunother., 22, 212-218.
164. Phillips, A.C. and Vousden, K.H. (1999) Human papillomavirus and cancer: the viral transforming genes. Cancer Surv., 33, 55-74.
165. Roth, J.A. and Cristian, R.J. (1997) Gene therapy for cancer: what have we done and where are we going? J. Natl Cancer Inst., 88, 21-39.
166. Bischoff, J.R., Kirn, D.H., Williams, A., Heise, C., Horn, S., Muna, M., Ng, L., Nye, J.A., Sampson-Johannes, A., Fattaey, A. and McCormick, F. (1996) An adenovirus mutant that replicates selectively in p53-deficient human tumor cells. Science, 274, 373-376.
167. Vogt, V.M. (1997) Retroviral virions and genomes. In Coffin, J.M., Hughes, S.H. and Varmus, H.E. (eds) Retroviruses. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, pp. 27-69.
168. Alani, R.M. and Münger, K. (1998) Human papillomaviruses and associated malignancies. J. Clin. Oncol., 16, 330-337.
169. Stewart, A.R., Lednicky, J.A., Benzick, U.S., Tevethia, M.J. and Butel, J.S. (1996) Identification of a variable region at the C-terminus of SV40 large T-antigen. Virology, 221, 355-361.